Replies to post #342969 on Elite Pharmaceuticals Inc (ELTP)

[Kscmb13]

What I'm concerned about, is the small increase from Q3 to Q4 for CNS by Lannett. Only a $1.5M increase yet, Elite somehow had a very significant increase in their CNS revenue. Remember 73% all of Elite revenue is due to Adderall IR & ER. Two drugs are responsible for more than $5M in revenue for Q1-2021.
Even if Elite had revenues exceeding $10m, do we really expect it to make an impact on the stock price?